CD34 and acute myeloid leukemia: Look and colleagues found that decreased CTNNA1 expression in CD34+CD38-CD123+Lin- cells from high risk del(5q) associated MDS or AML patients was associated with methylation of the CTNNA1 promoter, but not with point mutations of the residual allele in primary tumor cells [8].